Florian Vogl

Chief Tech/Sci/R&D Officer at IMMUTEP LIMITED

Health Technology

Consumer Services

Profile

Florian D.
Vogl is currently the Chief Medical Officer at Immutep Ltd.
He previously worked as the Head of Clinical Development Europe at Rainier Therapeutics, Inc. and as the Chief Medical Officer at Cellestia Biotech AG.
Dr. Vogl obtained a doctorate degree from Ludwig-Maximilians-Universität München.

Florian Vogl active positions

Companies	Position	Start
IMMUTEP LIMITED	Chief Tech/Sci/R&D Officer	2023-04-30

All active positions of Florian Vogl

Former positions of Florian Vogl

Companies	Position	End
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.	Corporate Officer/Principal	-
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.	Chief Tech/Sci/R&D Officer	-

See the detail of Florian Vogl's experience

Training of Florian Vogl

Ludwig-Maximilians-Universität München

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Florian Vogl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
IMMUTEP LIMITED	Health Technology

Private companies	2
Rainier Therapeutics, Inc. Rainier Therapeutics, Inc. BiotechnologyHealth Technology Rainier Therapeutics, Inc. operates as a biotechnology company that develops a targeted biologic for the potential treatment of metastatic bladder cancer. It provides Vofatamab, an antibody that is focused on the fibroblast growth factor of bladder and other cancer. The company was founded by Stephen Lau and is headquartered in San Leandro, CA.	Health Technology
Cellestia Biotech AG Cellestia Biotech AG Pharmaceuticals: MajorHealth Technology Cellestia Biotech AG manufactures anti-cancer drugs. Its pipeline product includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymphoma, and solid tumors. The firm holds a worldwide exclusive license on the intellectual property rights for the development and commercialization of CB-103 and related series of close analogues. The company was founded by Freddy Radtke, Michael Bauer, Richard Peck, Dirk Weber and Rajwinder Lehal in 2014 and is headquartered in Basel, Switzerland.	Health Technology